Literature DB >> 17237256

Intensity-dependent activation of extracellular signal-regulated protein kinase 5 in sensory neurons contributes to pain hypersensitivity.

Toshiyuki Mizushima1, Koichi Obata, Hirokazu Katsura, Jun Sakurai, Kimiko Kobayashi, Hiroki Yamanaka, Yi Dai, Tetsuo Fukuoka, Takashi Mashimo, Koichi Noguchi.   

Abstract

Alterations in the intracellular signal transduction pathway in primary afferents may contribute to pain hypersensitivity. Recently, we have reported that the phosphorylation of extracellular signal-regulated protein kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinase (MAPK) occurs in primary afferent neurons in response to noxious stimulation of the peripheral tissue, i.e., activity-dependent activation of ERK1/2 and p38 MAPK in dorsal root ganglion (DRG) neurons. In the present study, we investigated the phosphorylation of ERK5, also known as big MAPK1, in the DRG by noxious stimulation using immunohistochemistry. Capsaicin injection induced phosphorylated ERK5 (p-ERK5) in small-to-medium diameter sensory neurons with a peak at 2 min after capsaicin injection. Furthermore, we examined the p-ERK5 labeling in the DRG after noxious heat and cold stimuli and found a stimulus intensity-dependent increase in the number of activated neurons. Most of these p-ERK5-immunoreactive neurons were small- and medium-sized neurons, which coexpressed transient receptor potential (TRP) ion channel TRPV1 and TRPA1 after noxious heat and cold stimuli, respectively. In contrast, there was no change in ERK5 phosphorylation in the spinal dorsal horn. The i.t. administration of ERK5 antisense oligodeoxynucleotide reversed heat hyperalgesia, but not mechanical allodynia, produced by capsaicin injection. Taken together, these findings suggest that the in vivo activation of the ERK5 signaling pathway in sensory neurons by noxious stimulation may be, at least in part, correlated with functional activity and, further, involved in the development of pain hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237256     DOI: 10.1124/jpet.106.116749

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

Review 1.  Research progress of the role and mechanism of extracellular signal-regulated protein kinase 5 (ERK5) pathway in pathological pain.

Authors:  Li-Na Yu; Li-Hong Sun; Min Wang; Min Yan
Journal:  J Zhejiang Univ Sci B       Date:  2016 Oct.       Impact factor: 3.066

2.  Extracellular signal-regulated kinase 5 in the cerebrospinal fluid-contacting nucleus contributes to morphine physical dependence in rats.

Authors:  Chun-Guang Wang; Yan-Ling Ding; Tian-Fang Zheng; Jing-Qiu Wei; He Liu; Yu-Feng Chen; Jia-You Wang; Li-Cai Zhang
Journal:  J Mol Neurosci       Date:  2012-11-11       Impact factor: 3.444

Review 3.  The molecular basis of pain and its clinical implications in rheumatology.

Authors:  Brendan Bingham; Seena K Ajit; David R Blake; Tarek A Samad
Journal:  Nat Clin Pract Rheumatol       Date:  2009-01

Review 4.  TRP channels and analgesia.

Authors:  Louis S Premkumar; Mruvil Abooj
Journal:  Life Sci       Date:  2012-08-14       Impact factor: 5.037

5.  Inflammation-induced shift in spinal GABA(A) signaling is associated with a tyrosine kinase-dependent increase in GABA(A) current density in nociceptive afferents.

Authors:  Yi Zhu; Shiv Dua; Michael S Gold
Journal:  J Neurophysiol       Date:  2012-08-22       Impact factor: 2.714

6.  Activation of mitogen-activated protein kinase in descending pain modulatory system.

Authors:  Hiroki Imbe; Emiko Senba; Akihisa Kimura; Tomohiro Donishi; Isao Yokoi; Yoshiki Kaneoke
Journal:  J Signal Transduct       Date:  2010-12-01

7.  Protein kinase C modulation of thermo-sensitive transient receptor potential channels: Implications for pain signaling.

Authors:  Sravan Mandadi; Patricia J Armati; Basil D Roufogalis
Journal:  J Nat Sci Biol Med       Date:  2011-01

8.  ThermoTRP channels in nociceptors: taking a lead from capsaicin receptor TRPV1.

Authors:  Sravan Mandadi; Basil D Roufogalis
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.